Skip to content

Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma?

Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma?

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07446985
Enrollment
40
Registered
2026-03-03
Start date
2026-02-07
Completion date
2026-07-15
Last updated
2026-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Polycystic Ovary Syndrome

Brief summary

Women with polysyctic ovarian syndrome (PCOS) usually develop many complications including asthma. Nowdays, diet restriction combimed with phsyical exercises may improve both problems

Detailed description

Forty Women with asthma with PCOS will be enrolled to be catogrized to Group I or group II. Group I will enroll twenty females with PCOS and asthma who will apply forty minutes walking on treadmill three times per week. Also Group I will follow low calorie diet and daily metformin for 12 weeks. Group II will will enroll twenty females with PCOS and asthma who will follow low calorie diet and daily metformin for 12 weeks

Interventions

BEHAVIORALexercise plus limiitng diet

Group I will enroll twenty females with PCOS and asthma who will apply forty minutes walking on treadmill three times per week. Also Group I will follow low calorie diet and daily metformin for 12 weeks.

BEHAVIORALlimiting diet

Group II will will enroll twenty females with PCOS and asthma who will follow low calorie diet and daily metformin for 12 weeks

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

* PCOS women * women with asthma * obese women (calss I)

Exclusion criteria

* cardiac problems * renal problems * liver problems

Design outcomes

Primary

MeasureTime frameDescription
forced vital capcityit will be measured after 12 weeksit is a pulmonary function testing

Secondary

MeasureTime frameDescription
scale of fatigue severityIt will be measured after 12 weeksit is a questionaire assesing fatigue
waist hip ratioIt will be measured after 12 weeksit is a measure of excess weight
forced expiratory volumeIt will be measured after 12 weeksit is a pulmonary function testing at the first second of expiration
forced expiratory volume to forced expiratory capcityIt will be measured after 12 weeksit is a common ratio test in pulmonary function examiantions
body mass indexIt will be measured after 12 weeksit will be assessed on empty stomach and bladder
waist circumferenceit will be measured after 12 weeksit will be assessed at level of patient umblicus
luteinizing-hormone to follicle-stimulating-hormone ratioIt will be measured after 12 weeksit is an indicator on level of sex hormone production
TestosteroneIt will be measured after 12 weeksit is androgen hormone
Mini asthma quality of life questionnaireIt will be measured after 12 weeksit is a questioanire assessing life quality in asthma
DehydroepiandrosteroneIt will be measured after 12 weeksit is a hormone that body naturally produces in the adrenal gland

Countries

Egypt

Contacts

CONTACTAli MA Ismail, lecturer
ali.mohamed@pt.cu.edu.eg01005154209
CONTACTali mohamed
fatmaraed1994@gmail.com0201031321109
PRINCIPAL_INVESTIGATORAli MA Ismail, lecturer

Cairo University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026